VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CLVT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CLVTClarivate Plc
$1.89$1.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCLVTBalance Sheet

Clarivate Plc (CLVT) Balance Sheet

9Y historyFree accessUpdated daily

Total assets contracted 16% from $12.5B in 2024Q1 to $10.5B in 2026Q2, while D/E rose to 0.94 and cash fell to $217.7M, indicating strained liquidity and rising leverage.

Income StatementBalance SheetCash FlowRatios

CLVT Balance Sheet

Annual statement

CLVT Balance Sheet

Clarivate Plc (CLVT) balance sheet — 9-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Total Current Assets1.21B1.31B1.24B1.46B1.4B1.64B1.15B493.08M408.61M443.91M
Cash & Short-Term Investments217.7M329.2M295.2M370.7M348.8M587.61M257.73M76.13M25.57M53.19M
Cash Only217.7M329.2M295.2M370.7M348.8M587.61M257.73M76.13M25.57M53.19M
Short-Term Investments0000000000
Accounts Receivable827.9M821.7M798.3M908.3M872.1M906.43M737.73M333.86M331.3M317.81M
Days Sales Outstanding126.43122.16113.97126.11119.68176.27214.71125.07124.86126.41
Inventory000097.4M00031.03M52.76M
Days Inventory Outstanding----37.27---28.5648.85
Other Current Assets168.6M64.9M65.2M94.7M76.9M66.65M93.83M42.38M31.13M44.52M
Total Non-Current Assets9.27B9.76B10.25B11.24B12.55B18.55B13.64B3.3B3.3B3.56B
Property, Plant & Equipment88.3M99.3M107.1M106.8M113.4M169.88M168.62M103.49M20.64M23.01M
Fixed Asset Turnover25.16x24.73x23.87x24.61x23.46x11.05x7.44x9.41x46.92x39.88x
Goodwill1.34B1.57B1.57B2.02B2.88B7.9B6.04B1.33B1.28B1.31B
Intangible Assets7.73B8.01B8.44B9.01B9.44B10.39B7.37B1.83B1.96B2.16B
Long-Term Investments21.8M1.8M14.7M17.7M47.2M1.96M0000
Other Non-Current Assets86.5M66.3M67.5M43.1M50.7M48.75M31.33M18.63M26.56M60.03M
Total Assets10.49B11.07B11.49B12.71B13.94B20.18B14.79B3.79B3.71B4.01B
Asset Turnover0.22x0.22x0.22x0.21x0.19x0.09x0.08x0.26x0.26x0.23x
Asset Growth %-23.45%-3.66%-9.57%-8.88%-30.91%36.46%290.11%2.2%-7.38%-
Total Current Liabilities1.44B1.57B1.43B1.6B1.56B1.9B1.42B651M643.71M661.07M
Accounts Payable152.9M150.6M124.5M144.1M101.4M129.22M82.04M26.46M38.42M60.76M
Days Payables Outstanding65.9865.9452.2858.0338.875.3368.2427.4435.3756.26
Short-Term Debt18.3M101.5M20.6M24.4M26.7M62.75M28.6M9M60.34M45.34M
Deferred Revenue (Current)3.71B941.4M943.9M983.1M947.5M1.03B707.32M407.32M391.1M361.26M
Other Current Liabilities367.5M146.7M-20.6M321.9M326.4M348.01M57.75M26.87M00
Current Ratio0.85x0.84x0.87x0.91x0.89x0.86x0.81x0.76x0.63x0.67x
Quick Ratio0.85x0.84x0.87x0.91x0.83x0.86x0.81x0.76x0.59x0.59x
Cash Conversion Cycle60.45---118.15---118.06119
Total Non-Current Liabilities4.51B4.66B4.92B5.11B5.57B6.36B4.33B1.89B2.02B2.06B
Long-Term Debt4.24B4.32B4.52B4.72B4.97B5.46B3.46B1.63B1.93B1.97B
Capital Lease Obligations113.7M37.9M53.2M63.2M72.9M93.95M104.32M64.19M00
Deferred Tax Liabilities889.5M212.1M273.3M249.6M316.1M380.06M367M48.55M43.23M51.79M
Other Non-Current Liabilities75.8M86.2M55.9M41.9M171.4M370.59M362.2M130.7M24.84M22.61M
Total Liabilities5.95B6.23B6.35B6.71B7.13B8.26B5.76B2.54B2.66B2.72B
Total Debt4.26B4.48B4.59B4.81B5.1B5.61B3.63B1.72B1.99B2.01B
Net Debt4.04B4.15B4.3B4.44B4.76B5.03B3.37B1.65B1.96B1.96B
Debt / Equity0.94x0.92x0.89x0.80x0.75x0.47x0.40x1.38x1.89x1.57x
Debt / EBITDA8.86x5.41x10.17x--12.45x13.59x14.60x15.14x24.72x
Net Debt / EBITDA8.41x5.01x9.52x--11.15x12.62x13.96x14.94x24.07x
Interest Coverage-0.33x0.65x-0.95x-2.45x-13.76x-0.02x-2.16x-0.58x-0.81x-1.06x
Total Equity4.54B4.84B5.14B5.99B6.81B11.93B9.03B1.25B1.05B1.29B
Equity Growth %-30.7%-5.76%-14.24%-12.04%-42.88%32%623.59%18.85%-18.31%-
Book Value per Share7.107.197.418.9210.0418.6121.084.563.444.21
Total Shareholders' Equity4.54B4.84B5.14B5.99B6.81B11.93B9.03B1.25B1.05B1.29B
Common Stock12.82B12.81B12.98B11.74B11.74B11.83B9.99B2.14B16K16K
Retained Earnings-7.82B-7.51B-7.31B-6.65B-5.66B-1.6B-1.25B-890.89M-632.26M-390.1M
Treasury Stock00000-16.96M-196.04M000
Accumulated OCI-454.3M-453.1M-526.3M-495.3M-665.9M326.75M492.38M-4.88M5.36M13.98M
Minority Interest0000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityWeak
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Persistent losses and high leverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Shrinking Balance Sheet Amid Losses

Total assets contracted from $12.5B in 2024Q1 to $10.5B in 2026Q2, a 16% decline, while equity fell from $5.9B to $4.5B, as per reported figures, indicating ongoing balance sheet erosion.

The sequential decline in total assets and equity reflects both the impact of persistent net losses and potential asset impairments, as goodwill dropped from $2.0B to $1.3B over the period. This trend suggests that the company's asset base is shrinking faster than debt reduction, which may signal deteriorating business quality. Investors should monitor whether this contraction stabilizes or accelerates, as it could further pressure leverage ratios.

Leverage Creeps Higher as Debt Persists

Total debt remained near $4.3B while equity fell, pushing D/E from 0.81 in 2024Q1 to 0.94 in 2026Q2, as reported in financial statements, indicating rising leverage despite modest debt paydown.

Although total debt declined by roughly $500M over the period, the faster erosion of equity has increased the debt-to-equity ratio, suggesting that deleveraging is not keeping pace with balance sheet shrinkage. The absolute debt level remains substantial relative to cash and equity, implying that refinancing risk and interest burden could become more pronounced if operating losses persist. The company's ability to service this debt depends on sustaining positive operating cash flow, which has been volatile.

Goodwill Impairments Signal Acquisition Risk

Goodwill fell from $2.0B in 2024Q1 to $1.3B in 2026Q2, a 35% reduction, as per reported figures, suggesting significant impairments that may reflect overpayment for past acquisitions.

The sharp decline in goodwill, alongside a shrinking asset base, indicates that the company has recognized impairments, likely due to lower expected future cash flows from acquired businesses. This raises questions about the quality of the asset base and the sustainability of the business model, as the remaining $1.3B goodwill still represents a meaningful portion of total assets. Investors should assess whether further impairments are likely, which could erode equity further.

Retained Losses Deplete Equity Buffer

Accumulated deficit deepened from -$6.7B in 2024Q1 to -$7.8B in 2026Q2, as reported in SEC filings, reflecting cumulative net losses that have consumed over $1B of equity.

The widening negative retained earnings is a direct consequence of persistent net losses, which have exceeded $1.1B over the past ten quarters. This depletion of equity reduces the cushion for creditors and may limit financial flexibility, as the company cannot rely on retained earnings to fund operations or investments. The lack of dividend payments and negative share repurchases in recent quarters suggests that capital is being conserved, but the equity base remains under pressure.

Liquidity Tightens as Cash Dwindles

Cash fell from $361.8M in 2024Q1 to $217.7M in 2026Q2, while the current ratio slipped to 0.85, as per reported figures, indicating a shrinking liquidity buffer against short-term obligations.

The current ratio below 1.0 suggests that current liabilities exceed current assets, which may indicate potential difficulty in meeting short-term obligations without relying on cash flow or external financing. Cash levels have declined by nearly 40% over the period, and with operating cash flow volatile, the company's ability to absorb shocks appears limited. This tight liquidity position warrants close monitoring, especially if revenue continues to decline.

Deferred Revenue Masks Underlying Weakness

Deferred revenue fluctuated between $875.7M and $1.0B over the past ten quarters, as per financial statements, but its stability may obscure the true pace of revenue recognition and customer churn.

While deferred revenue has remained relatively stable, this could be misleading if the composition is shifting toward shorter-term contracts or if renewals are weakening. The stability might mask a decline in new business, as the income statement shows revenue contraction. Investors should examine the quality of deferred revenue and whether it is being drawn down faster than it is being replenished, which could signal future revenue pressure.

CLVT — Frequently Asked Questions

Quick answers to the most common questions about buying CLVT stock.

What are the total assets of Clarivate Plc (CLVT)?

As of 2025, Clarivate Plc (CLVT) had total assets of $11.07B including $1.31B in current assets.

How much debt does Clarivate Plc (CLVT) have?

Clarivate Plc (CLVT) carries total debt of $4.48B, offset by $329.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Clarivate Plc?

Clarivate Plc (CLVT) has total shareholders' equity (book value) of $4.84B ($7.19 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Clarivate Plc's current ratio and liquidity?

Clarivate Plc (CLVT) reported a current ratio of 0.84x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.